The 3rd EBOVAC1/2 Annual meeting will be held in Amsteram, the Netherlands 8-10 January 2018. Participants include consortium members and representatives of sites where the project clinical trials are being carried out.
An Ebovac2 poster was selected among 13 out of approx. 2 500 posters on the top rated of the...
What is Ebola?
Phase 2 trials
Find out more about EBOVAC2 trials
EBOVAC2 is organised into 6 workpackages (WP)
Contributes to efforts to tackle a wide range of challenges in Ebola research
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 115861. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA
By continuing your navigation, you accept the deposit of third-party cookies intended to offer you videos, sharing buttons, content uploads from social platforms. Learn more
Measure of audience
This site uses audience measurement and analysis cookies, such as Google Analytics, in order to evaluate and improve our website.